Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

People with alopecia areata are more likely to have other immune-related conditions.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Different γδ T cell types have unique roles in causing alopecia areata.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Potential therapeutic targets for scarring hair loss are identified.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

Parental uveitis increases offspring's risk and severity of autoimmune eye disease.

Cyclophosphamide often causes gastrointestinal issues, hair loss, and low blood cell counts in Chinese patients with autoimmune diseases.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Key proteins and potential drugs for treating alopecia areata were identified.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Alopecia areata involves immune response and gene changes affecting hair loss.

A woman developed alopecia after her second Pfizer vaccine but regrew her hair with treatment and had no issues after a booster shot.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Gut health may influence Alopecia Areata, suggesting new treatments.

Folate receptor β helps suppress the immune system in macrophages and affects cancer growth and hair health.

Alopecia can often be managed effectively with various treatments, but early diagnosis is crucial for preventing permanent hair loss.

Urban air pollution worsens hair loss in alopecia areata by increasing immune response.

Lupus Panniculitis can be an early sign of Systemic Lupus Erythematosus.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

The model helps understand and improve treatments for alopecia areata by simulating hair growth and immune cell interactions.